Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Omnicell, Inc. (OMCL)

86.56   0.26 (0.3%) 09-24 15:30
Open: 85.58 Pre. Close: 86.3
High: 87.42 Low: 84.86
Volume: 347,716 Market Cap: 3,834(M)
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 87.5 - 88.11 88.11 - 88.59
Low: 83.71 - 84.36 84.36 - 84.87
Close: 85.71 - 86.72 86.72 - 87.5

Technical analysis

as of: 2022-09-23 4:26:25 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 118.11     One year: 129.85
Support: Support1: 84.86    Support2: 70.6
Resistance: Resistance1: 101.12    Resistance2: 111.18
Pivot: 96.29
Moving Average: MA(5): 89.31     MA(20): 98.35
MA(100): 108.95     MA(250): 135.22
MACD: MACD(12,26): -5.1     Signal(9): -3.9
Stochastic oscillator: %K(14,3): 7.2     %D(3): 8.5
RSI: RSI(14): 24.1
52-week: High: 187.28  Low: 84.86
Average Vol(K): 3-Month: 534 (K)  10-Days: 478 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ OMCL ] has closed above bottom band by 7.7%. Bollinger Bands are 90.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.

Headline News

Fri, 23 Sep 2022
Benchmark Lowers Omnicell (NASDAQ:OMCL) Price Target to $157.00 - MarketBeat

Wed, 21 Sep 2022
Health Care Sector Update for 09/21/2022: OMCL,VTRS,SHC - Nasdaq

Tue, 20 Sep 2022
Omnicell says advance services to steer profitable growth: Investor Day (NASDAQ:OMCL) - Seeking Alpha

Thu, 15 Sep 2022
Omnicell (NASDAQ:OMCL) Research Coverage Started at KeyCorp - MarketBeat

Fri, 09 Sep 2022
Omnicell (NASDAQ:OMCL) Research Coverage Started at Bank of America - MarketBeat

Fri, 02 Sep 2022
Oversold Conditions For Omnicell (OMCL) - Nasdaq

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Health Information Services
Shares Out. 44 (M)
Shares Float 43 (M)
% Held by Insiders 1.4 (%)
% Held by Institutions 110.2 (%)
Shares Short 3,450 (K)
Shares Short P.Month 3,410 (K)

Stock Financials

EPS 1.26
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 24.67
Profit Margin (%) 4.8
Operating Margin (%) 6.3
Return on Assets (ttm) 2.4
Return on Equity (ttm) 5.6
Qtrly Rev. Growth 21.5
Gross Profit (p.s.) 12.53
Sales Per Share 28.44
EBITDA (p.s.) 3.02
Qtrly Earnings Growth -53.5
Operating Cash Flow 77 (M)
Levered Free Cash Flow 33 (M)

Stock Valuations

PE Ratio 68.15
PEG Ratio 0
Price to Book value 3.5
Price to Sales 3.04
Price to Cash Flow 49.74

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.